- Issuer ticker
-
CRBU
- Reported as of
-
20 Feb 2026
- Net transaction value
-
$0
- SEC form
-
4
- Accepted by SEC
-
20 Feb 2026, 17:27:05 UTC
Filing notes and source
Key filing fact
Scott Braunstein filed Form 4 for Caribou Biosciences, Inc. (CRBU) on 20 Feb 2026.
Key facts
- This page summarizes Scott Braunstein's Form 4 filing for Caribou Biosciences, Inc. (CRBU).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 20 Feb 2026, 17:27.
Change
- Previous filing in this sequence was filed on 02 Feb 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reporting Owners (1)
CIK 0001643875
Primary reporting owner
Braunstein Scott
- Relationship
-
Director
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CRBU
transaction
Derivative
Option to purchase Common Stock
Award
- Transaction value
- $0
- Shares
- +45,000
- Change %
- Price
-
$0.000000
- Shares after
- 45,000
- Date
- 20 Feb 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 45,000
- Exercise price
- $1.80
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Explanation of responses
1 footnote